Nct Heidelberg - National Center For Tumor Diseases (Nct) Heidelberg

Nct Heidelberg - National Center For Tumor Diseases (Nct) Heidelberg company information, Employees & Contact Information

The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the University Hospital Heidelberg (UKHD), the Medical Faculty of the University of Heidelberg and the Thorax Hospital Heidelberg. The aim of the NCT Heidelberg is to transfer promising approaches from cancer research into clinical practice as quickly as possible, thus benefiting patients. This applies to both diagnosis and treatment, in aftercare or prevention. Participation in clinical studies opens up access to innovative therapies. The NCT Heidelberg is thus a pioneer in transferring new research results from the laboratory to the clinic. The NCT Heidelberg, founded in 2004, is part of the NCT with further locations in Berlin, Dresden, South-West (Tübingen-Stuttgart/Ulm), WERA (Würzburg, Erlangen, Regensburg, Augsburg) and West (Essen/Cologne).
Looking for a particular Nct Heidelberg - National Center For Tumor Diseases (Nct) Heidelberg employee's phone or email?

Nct Heidelberg - National Center For Tumor Diseases (Nct) Heidelberg Questions

News

Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility - Wiley Online Library

Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility Wiley Online Library

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology - Nature

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology Nature

Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold - Molecular Cancer

Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold Molecular Cancer

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent but clinically inapparent in cancer patients under immune checkpoint therapy - medRxiv

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent but clinically inapparent in cancer patients under immune checkpoint therapy medRxiv

Breast cancer: Towards individualized therapy - Deutsches Krebsforschungszentrum

Breast cancer: Towards individualized therapy Deutsches Krebsforschungszentrum

Heidelberg Congress Center, Germany - e-architect

Heidelberg Congress Center, Germany e-architect

Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling - Nature

Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling Nature

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling - Acta Neuropathologica Communications

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling Acta Neuropathologica Communications

New Approach in the Analysis of Immune Responses to Cancer - Deutsches Krebsforschungszentrum

New Approach in the Analysis of Immune Responses to Cancer Deutsches Krebsforschungszentrum

New Bridge over the Neckar River in Heidelberg - e-architect

New Bridge over the Neckar River in Heidelberg e-architect

DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia - Nature

DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia Nature

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype - Acta Neuropathologica Communications

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype Acta Neuropathologica Communications

Stadtwerke Heidelberg Tower Building - e-architect

Stadtwerke Heidelberg Tower Building e-architect

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma - Nature

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma Nature

Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions - Nature

Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions Nature

Stadtwerke Heidelberg Energie Park + Building - e-architect

Stadtwerke Heidelberg Energie Park + Building e-architect

Characterization of rare germline variants in familial multiple myeloma - Nature

Characterization of rare germline variants in familial multiple myeloma Nature

A vaccine targeting mutant IDH1 in newly diagnosed glioma - Nature

A vaccine targeting mutant IDH1 in newly diagnosed glioma Nature

Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma - Nature

Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma Nature

Top Nct Heidelberg - National Center For Tumor Diseases (Nct) Heidelberg Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant